Financial Advisors Network’s Vertex Pharmaceuticals VRTX Stock Holding History

Financial Advisors Network’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.6M	Buy	+5,827	New	+$2.72M	0.36%	48
2025 Q1	–	Sell	-5,518	Closed	-$2.22M	–	215
2024 Q4	$2.22M	Buy	+5,518	New	+$2.56M	0.37%	51
2019 Q1	–	Sell	-6,247	Closed	-$1.03M	–	117
2018 Q4	$1.03M	Buy	+6,247	New	+$1.08M	0.64%	32
2018 Q2	$1.01M	Buy	+5,969	New	+$925K	0.61%	36

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Financial Advisors Network's VRTX Position: Q1 2026 in Review

Financial Advisors Network opened a new position in Vertex Pharmaceuticals (VRTX) in Q1 2026: 5,827 shares worth $2.6M. The stake represents 0.36% of the portfolio and ranks #48 among its holdings. This is a return to the name: Financial Advisors Network previously reported a position in VRTX as recently as Q4 2024.

Financial Advisors Network first reported a position in VRTX in Q2 2018 and has held it in 4 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

Financial Advisors Network held 5,827 shares of Vertex Pharmaceuticals worth $2.6M as of Q1 2026.
Vertex Pharmaceuticals was a new Financial Advisors Network position in Q1 2026.
Vertex Pharmaceuticals made up 0.36% of Financial Advisors Network's portfolio in Q1 2026, its #48 holding.
Financial Advisors Network first reported a position in Vertex Pharmaceuticals in Q2 2018 and has held it in 4 quarters since.
1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Financial Advisors Network's 13F filing for Q1 2026, filed 15 May 2026.